Myocarditis Clinical Trials

47 recruitingLast updated: June 18, 2026

There are 47 actively recruiting myocarditis clinical trials across 18 countries. Studies span Phase 3, Not Applicable, Phase 4, Phase 2. Top locations include Paris, France, Rochester, Minnesota, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Myocarditis Trials at a Glance

47 actively recruiting trials for myocarditis are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Phase 3 with 7 trials, with the heaviest enrollment activity in Paris, Rochester, and Houston. Lead sponsors running myocarditis studies include Assistance Publique - Hôpitaux de Paris, Scientific Institute San Raffaele, and First Affiliated Hospital Xi'an Jiaotong University.

Browse myocarditis trials by phase

Treatments under study

About Myocarditis Clinical Trials

Looking for clinical trials for Myocarditis? There are currently 27 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Myocarditis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Myocarditis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 47 trials

Recruiting

BEAT-SHOCK Registry

Cardiogenic ShockMyocardial Infarction (MI)Acute Decompensated Heart Failure+4 more
University Hospital, Basel, Switzerland8,000 enrolled1 locationNCT07643610
Recruiting

AI-powered ECG Analysis for Deadly Arrhythmias and ICI Myocarditis

Immune Checkpoint Inhibitor-Related MyocarditisArrhythmiaLong QT Syndrome
Groupe Hospitalier Pitie-Salpetriere127,000 enrolled1 locationNCT07644715
Recruiting

ATROPOS: Survival Analysis of ICI-associated Myocarditis

Immune Checkpoint Inhibitor-associated Myocarditis
Groupe Hospitalier Pitie-Salpetriere1,500 enrolled1 locationNCT07633587
Recruiting

EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases

PericarditisRheumatoid ArthritisSarcoidosis+10 more
Assistance Publique - Hôpitaux de Paris5,000 enrolled1 locationNCT07077304
Recruiting

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

CardiomyopathyCardiovascular DiseasesHeart Valve Diseases+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University2,000 enrolled1 locationNCT07617844
Recruiting

Global Cardio Oncology Registry

Breast CancerCardiotoxicityCardiovascular Diseases+2 more
The Cleveland Clinic5,000 enrolled1 locationNCT05598879
Recruiting
Phase 2

[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation

Myocarditis Due to DrugCardiac SarcoidosisAcute Cellular Graft Rejection
John O. Prior69 enrolled1 locationNCT05499637
Recruiting

Mayo AVC Registry and Biobank

CardiomyopathiesCardiovascular DiseasesSarcoidosis+14 more
Mayo Clinic1,000 enrolled2 locationsNCT03049254
Recruiting
Phase 3

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

Heart FailureCardiomyopathiesMyocarditis+2 more
Niguarda Hospital80 enrolled10 locationsNCT06158698
Recruiting

The Heart Hive - Cardiomyopathy Study

CardiomyopathiesMyocarditis
Imperial College London10,000 enrolled1 locationNCT04612296
Recruiting
Phase 3

Colchicine Versus Placebo in Acute Myocarditis Patients

Acute Myocarditis
Assistance Publique - Hôpitaux de Paris300 enrolled2 locationsNCT05855746
Recruiting
Phase 3

Non-Steroidal Anti-Inflammatory Drugs in Acute Myocarditis

Myocarditis Acute
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III150 enrolled1 locationNCT06686862
Recruiting

COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry

PericarditisMyocarditis
Ottawa Heart Institute Research Corporation400 enrolled1 locationNCT05046002
Recruiting

Multimodal Analysis of Endomyocardial Biopsies

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Heart Transplantation+4 more
University Hospital, Essen216 enrolled1 locationNCT07359690
Recruiting

The Application of T1 Mapping in Real-World

Hypertrophic Cardiomyopathy (HCM)MyocarditisMyocardial Infarction (MI)+2 more
Chinese Academy of Medical Sciences, Fuwai Hospital2,000 enrolled1 locationNCT07354646
Recruiting
Not Applicable

Cell Free DNA in Cardiac Sarcoidosis

HealthySarcoidosisST Elevation Myocardial Infarction+1 more
Nabeel Hamzeh120 enrolled2 locationsNCT03858777
Recruiting

IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION

Heart FailureLong COVID SyndromeMyocarditis+2 more
Johann Wolfgang Goethe University Hospital6,000 enrolled1 locationNCT04444128
Recruiting

Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis

Viral Myocarditis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology300 enrolled1 locationNCT06742008
Recruiting

Genetic Determinants of Myocarditis Induced by Immune-checkpoint Inhibitors

ICI-Myocarditis
Assistance Publique - Hôpitaux de Paris500 enrolled1 locationNCT06734689
Recruiting
Not Applicable

Quantitative Cardiac Parametric Mapping

Cardiomyopathy, Myocarditis, Ischemic Heart Disease
Medical University of South Carolina240 enrolled1 locationNCT02855554